JP2004535197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535197A5 JP2004535197A5 JP2003510787A JP2003510787A JP2004535197A5 JP 2004535197 A5 JP2004535197 A5 JP 2004535197A5 JP 2003510787 A JP2003510787 A JP 2003510787A JP 2003510787 A JP2003510787 A JP 2003510787A JP 2004535197 A5 JP2004535197 A5 JP 2004535197A5
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- elution
- chromatography
- solution
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000029816 Collagenase Human genes 0.000 claims description 49
- 108060005980 Collagenase Proteins 0.000 claims description 49
- 229960002424 collagenase Drugs 0.000 claims description 37
- 238000010828 elution Methods 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- 108010071626 caseinase Proteins 0.000 claims description 8
- 238000011210 chromatographic step Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 229920002451 polyvinyl alcohol Polymers 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000004587 chromatography analysis Methods 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 108090001092 clostripain Proteins 0.000 description 11
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 241000193159 Hathewaya histolytica Species 0.000 description 8
- 238000001042 affinity chromatography Methods 0.000 description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 7
- 229920002223 polystyrene Polymers 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 108010089930 2-furanacryloyl-leucyl-glycyl-prolyl-alanine Proteins 0.000 description 4
- 108090000145 Bacillolysin Proteins 0.000 description 4
- 102000035092 Neutral proteases Human genes 0.000 description 4
- 108091005507 Neutral proteases Proteins 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- ZLFQNOJSYZSINX-PVJKAEHXSA-N (2s)-2-[[(2s)-1-[2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]propanoic acid Chemical compound N([C@@H](CC(C)C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)C(=O)\C=C\C1=CC=CO1 ZLFQNOJSYZSINX-PVJKAEHXSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000001044 red dye Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000005571 anion exchange chromatography Methods 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- RTLULCVBFCRQKI-UHFFFAOYSA-N 1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=1)=CC=C(S(O)(=O)=O)C=1NC1=NC(Cl)=NC(Cl)=N1 RTLULCVBFCRQKI-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 101000882911 Hathewaya histolytica Clostripain Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- OVSNDJXCFPSPDZ-UHFFFAOYSA-N Reactive red 120 Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=CC(NC=3N=C(NC=4C=CC(NC=5N=C(NC=6C7=C(O)C(N=NC=8C(=CC=CC=8)S(O)(=O)=O)=C(C=C7C=C(C=6)S(O)(=O)=O)S(O)(=O)=O)N=C(Cl)N=5)=CC=4)N=C(Cl)N=3)=C2C(O)=C1N=NC1=CC=CC=C1S(O)(=O)=O OVSNDJXCFPSPDZ-UHFFFAOYSA-N 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000012504 chromatography matrix Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012045 crude solution Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000007693 zone electrophoresis Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10131994 | 2001-07-02 | ||
| DE10134347A DE10134347B4 (de) | 2001-07-02 | 2001-07-14 | Verfahren zur Aufreinigung eines Enzyms |
| PCT/EP2002/006021 WO2003004628A2 (de) | 2001-07-02 | 2002-06-01 | Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004535197A JP2004535197A (ja) | 2004-11-25 |
| JP2004535197A5 true JP2004535197A5 (enExample) | 2008-05-08 |
| JP4266817B2 JP4266817B2 (ja) | 2009-05-20 |
Family
ID=26009625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510787A Expired - Fee Related JP4266817B2 (ja) | 2001-07-02 | 2002-06-01 | 酵素の精製方法およびその方法で製造された精製済み酵素並びに該酵素の用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7083964B2 (enExample) |
| EP (1) | EP1402008B1 (enExample) |
| JP (1) | JP4266817B2 (enExample) |
| CN (1) | CN1308442C (enExample) |
| AT (1) | ATE302844T1 (enExample) |
| AU (1) | AU2002354696A1 (enExample) |
| CA (1) | CA2447818C (enExample) |
| WO (1) | WO2003004628A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
| DE10331171A1 (de) * | 2003-07-09 | 2005-01-27 | Nordmark Arzneimittel Gmbh & Co. Kg | Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung |
| US7824711B2 (en) | 2003-12-11 | 2010-11-02 | Isto Technologies, Inc. | Particulate cartilage system |
| EP1916964A4 (en) | 2005-08-26 | 2015-11-04 | Zimmer Inc | IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES |
| US20070181479A1 (en) * | 2005-11-21 | 2007-08-09 | Pentax Corporation | Column and method of manufacturing the column |
| US7811560B2 (en) * | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| AU2008240191B2 (en) | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
| US10071143B1 (en) | 2007-05-03 | 2018-09-11 | The Research Foundation For The State University Of New York | Methods for non-surgical treatment of carpal tunnel syndrome |
| US20100159564A1 (en) * | 2007-11-30 | 2010-06-24 | Dwulet Francis E | Protease resistant recombinant bacterial collagenases |
| US8853261B2 (en) * | 2008-01-21 | 2014-10-07 | Laila Nutraceuticals | Nutraceutical composition from Garcinia mangostana |
| EP2130551B1 (en) | 2008-06-02 | 2012-06-06 | Roche Diagnostics GmbH | Improved purification of collagenases from clostridium histolyticum liquid culture |
| EP4015627B1 (en) | 2012-01-12 | 2023-09-27 | Endo Global Ventures | Clostridium histolyticum enzyme |
| US9636385B2 (en) | 2012-10-24 | 2017-05-02 | The Research Foundation For The State University Of New York | Use of collagenase to treat glaucoma |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| GB201507207D0 (en) * | 2015-04-24 | 2015-06-10 | Givaudan Sa | Enzymes and applications thereof |
| KR20230003601A (ko) | 2017-03-01 | 2023-01-06 | 엔도 벤쳐즈 리미티드 | 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법 |
| KR20240001279A (ko) | 2017-03-28 | 2024-01-03 | 엔도 벤쳐즈 리미티드 | 개선된 콜라게나제 생성 방법 |
| CN112996801A (zh) * | 2018-11-26 | 2021-06-18 | 北卡罗来纳州大学 | 用于捕获宿主细胞蛋白的肽配体 |
| JP2022529565A (ja) * | 2019-02-14 | 2022-06-23 | ノルドマルク ファーマ ゲーエムベーハー | コラゲナーゼタイプｉ、コラゲナーゼタイプｉｉ、中性プロテアーゼ、およびクロストリパインからなる群から選択される少なくとも１種の酵素のクロマトグラフィー精製 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5332503A (en) * | 1993-04-16 | 1994-07-26 | Baxter International Inc. | Process for purifying collagenase |
| DE4445891A1 (de) * | 1994-12-22 | 1996-06-27 | Boehringer Mannheim Gmbh | Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden |
-
2002
- 2002-06-01 CN CNB028131347A patent/CN1308442C/zh not_active Expired - Lifetime
- 2002-06-01 AU AU2002354696A patent/AU2002354696A1/en not_active Abandoned
- 2002-06-01 AT AT02782420T patent/ATE302844T1/de not_active IP Right Cessation
- 2002-06-01 EP EP02782420A patent/EP1402008B1/de not_active Expired - Lifetime
- 2002-06-01 CA CA2447818A patent/CA2447818C/en not_active Expired - Lifetime
- 2002-06-01 WO PCT/EP2002/006021 patent/WO2003004628A2/de not_active Ceased
- 2002-06-01 US US10/478,545 patent/US7083964B2/en not_active Expired - Lifetime
- 2002-06-01 JP JP2003510787A patent/JP4266817B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004535197A5 (enExample) | ||
| JP4266817B2 (ja) | 酵素の精製方法およびその方法で製造された精製済み酵素並びに該酵素の用途 | |
| US4264738A (en) | Process for purification of proteolytic enzymes | |
| JP4559216B2 (ja) | 液体中の夾雑物からアルブミンを分離する方法、使用及びキット | |
| Kaufmann | Unstable proteins: how to subject them to chromatographic separations for purification procedures | |
| JP3662020B2 (ja) | コラゲナーゼを精製する方法 | |
| AU2011234521B2 (en) | A process for purifying Vitamin K dependent proteins such as coagulation factor IX | |
| JPH0231687A (ja) | 血清アルブミンの純化方法 | |
| JPH10506924A (ja) | 動物性タンパク質を含まないエリトロポイエチンの製造のための方法 | |
| JPS5839513B2 (ja) | 精製したトリプシンおよびトリプシン様酵素の貯蔵法 | |
| CA2178208C (en) | Purification of vitamin-k dependent proteins by membrane chromatography | |
| EP1343873B1 (en) | A method for the purification of chymosin | |
| EP1507858B1 (en) | Method for the purification of a rhizomucor aspartic protease | |
| KR19980703851A (ko) | 에리트로포이에틴과 같은 당단백질의 정제 방법 | |
| BRPI0210106B1 (pt) | Processo para a purificação de caseinase, colagenases dos tipos i e ii e clostripaína produzidas em um meio pela fermentação de clostridium histolyticum | |
| US3926730A (en) | Separation and purification of alpha-amylase | |
| JPH02504588A (ja) | ウロキナーゼ化合物の回収 | |
| US4030977A (en) | Method for purification of physiologically active substance using enzyme-enzyme inhibitor system | |
| CZ328594A3 (en) | PURIFICATION OF CRINGL-CONTAINING PEPTIDES, PARTICULARLY t-PA | |
| JP2000078971A (ja) | Ｄ−、ｌ−アミノ酸エステルよりオリゴペプチドを合成する新規酵素およびこれを生産する微生物 | |
| Turchi et al. | Improved purification of α-amylase isolated from Rhizomucor pusillus by affinity chromatography | |
| JP2022529565A (ja) | コラゲナーゼタイプｉ、コラゲナーゼタイプｉｉ、中性プロテアーゼ、およびクロストリパインからなる群から選択される少なくとも１種の酵素のクロマトグラフィー精製 | |
| CN1948471B (zh) | 一种羧肽酶b的制备方法及其组合物 | |
| SU979354A1 (ru) | Способ получени сорбента | |
| KR830001822B1 (ko) | 유로 키나제의 제조방법 |